BioMedical SIG #10

BioMedical SIG #10

The KHAN/w4i/LDC ecosystem: collaborative drug discovery and commercialization with academic innovators in Europe

Book Your Place

This event has now expired

This is the second webinar in the BioMedical SIG webinar series, “From Research to Development – Paths to Cross the Valley of Death in Life Sciences”, which showcases initiatives available to European KTOs to maturate technologies with potential in TRL and CRL, without the creation of a spin-off.

In this session, speakers Peter Nussbaumer and Gernot Faustmann will present the KHAN/w4i/LDC initiative. This collaborative drug discovery platform facilitates the translation of world-class science into innovative therapies for the benefit of patients. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. They focus on first-in-class therapies for attractive markets with a high unmet medical need.

This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

Great networking, new knowledge and inspiration!

Jonas Rimbäck

University of Gothenburg, Sweden

testimonial

Fruitful discussion.

Cecile Henrich-Burkhardt

Technical University of Munich, Germany

testimonial

Working and Learning with old and new friends – best way to do it!

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!

Ilse Sienaert

KU Leuven R&D, Belgium

testimonial

International presence is amazing, so many countries, universities... represented here!!

Christian Massus

SATT Aquitaine, France